Merck & Co., Inc. Submits New Data to FDA for Widened Gardasil Use in Women 27 to 45

Reuters -- Merck & Co (MRK.N) on Wednesday said it had provided U.S. regulators with new information needed for approval to market its Gardasil cervical cancer vaccine to women between the ages of 27 to 45.